Drug intelligence / Profile preview

PDC-1421

Development stage
Phase 2
Lead developer
BioLite
Modality
Small Molecules
Administration
Oral
01

Overview

PDC-1421 is an oral botanical formulation derived from the root of Polygala tenuifolia (Radix polygalae), developed as a potential treatment for major depressive disorder (MDD) and attention-deficit hyperactivity disorder (ADHD). The active pharmaceutical ingredient, also known as Radix polygalae extract, acts primarily as a norepinephrine transporter (NET) inhibitor, thereby modulating norepinephrine reuptake in the brain. This mechanism is associated with antidepressant and sedative effects. Clinical studies have shown that PDC-1421 can significantly reduce depressive symptoms and improve focus in ADHD patients, with a favorable safety profile compared to traditional antidepressants[1][2][3][5][6]. The drug is being developed by BioLite (a subsidiary of ABVC BioPharma), with involvement from several academic institutions.

Other names
Radix polygalae extract PDC-1421Polygala tenuifolia Willd. extract
02

Targets

NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on PDC-1421.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDC-1421.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call